<DOC>
	<DOC>NCT01710670</DOC>
	<brief_summary>To evaluate if Brivaracetam (BRV) influences the psychomotor and cognitive impairing effects of Ethanol</brief_summary>
	<brief_title>A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ethanol</mesh_term>
	<criteria>Healthy male volunteers with the age between 18 and 55 years old Subject has participated or is participating in any other clinical studies of investigational drug or another investigational medical product within the last 3 months or has participated in 4 or more Investigational Medicinal Product (IMP) studies within 1 year prior to screening Subject is not healthy (eg, taking any drug treatments except use of Paracetamol, excessive amount of alcohol, cigarettes, caffeine consumption, having a positive drug / alcohol abuse, having abnormal safety parameters) Subject has not been vaccinated for hepatitis Subjects has consumed any grapefruits, grapefruits juice, grapefruitcontaining products or star fruit within 14 days prior to dosing or not able to refrain from these products during the study Subject has Ethanol intolerance Subject has a known hypersensitivity to any components of the Investigational Medicinal Product (IMP) Subject has made a blood donation or a comparable blood loss (500 ml) within the last 3 months prior to screening subject is an employee of the investigator or study center or subject is a first line family member of an employee working in the respective study center or of the investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Brivaracetam</keyword>
	<keyword>Ethanol</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Interaction</keyword>
</DOC>